← Open Payments lookup

DAVID COFFMAN: Open Payments

NPI 1578851739 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,855 in 146 payments from 19 companies in 2025. Trend: 2023 $3,009 · 2024 $2,668 · 2025 $2,855

Food & beverage: $2,855
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)19$424
Otsuka America Pharmaceutical, Inc.15$338
Neurocrine BioSciences, Inc.10$290
Takeda Pharmaceuticals U.S.A., Inc.13$244
Axsome Therapeutics, Inc.7$228
Corium, LLC10$228
ABBVIE INC.22$210
Lundbeck LLC12$204
Supernus Pharmaceuticals, Inc.11$188
Janssen Pharmaceuticals, Inc6$111

Products named: REXULTI, CAPLYTA, INGREZZA, TRINTELLIX, Auvelity, Azstarys, VRAYLAR, Qelbree.

Industry payments across AL — which companies pay providers there.